Cargando…

Preclinical Therapy with Vitamin D3 in Experimental Encephalomyelitis: Efficacy and Comparison with Paricalcitol

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). MS and its animal model called experimental autoimmune encephalomyelitis (EAE) immunopathogenesis involve a plethora of immune cells whose activation releases a variety of proinflammatory mediators and fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mimura, Luiza Ayumi Nishiyama, Fraga-Silva, Thais Fernanda de Campos, de Oliveira, Larissa Ragozzo Cardoso, Ishikawa, Larissa Lumi Watanabe, Borim, Patrícia Aparecida, Machado, Carla de Moraes, Júnior, José de Anchieta de Castro e Horta, da Fonseca, Denise Morais, Sartori, Alexandrina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918993/ https://www.ncbi.nlm.nih.gov/pubmed/33671896 http://dx.doi.org/10.3390/ijms22041914

Ejemplares similares

Gliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering Neuroinflammation
por: Fraga-Silva, Thais Fernanda de Campos, et al.
Publicado: (2019)

Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog
por: Zorzella-Pezavento, Sofia Fernanda Gonçalves, et al.
Publicado: (2017)

Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
por: Chiuso-Minicucci, Fernanda, et al.
Publicado: (2015)

Calcitriol Prevents Neuroinflammation and Reduces Blood-Brain Barrier Disruption and Local Macrophage/Microglia Activation
por: de Oliveira, Larissa Ragozo Cardoso, et al.
Publicado: (2020)

Selenization of S. cerevisiae increases its protective potential in experimental autoimmune encephalomyelitis by triggering an intestinal immunomodulatory loop
por: de Campos Fraga-Silva, Thais Fernanda, et al.
Publicado: (2020)

Candida tropicalis Systemic Infection Redirects Leukocyte Infiltration to the Kidneys Attenuating Encephalomyelitis
por: Munhoz-Alves, Natália, et al.
Publicado: (2021)

Systemic Administration of Proteoglycan Protects BALB/c Retired Breeder Mice from Experimental Arthritis
por: Ishikawa, Larissa Lumi Watanabe, et al.
Publicado: (2016)

Previous infection with Staphylococcus aureus strains attenuated experimental encephalomyelitis
por: França, Thais Graziela Donegá, et al.
Publicado: (2014)

Systemic Infection by Non-albicans Candida Species Affects the Development of a Murine Model of Multiple Sclerosis
por: Fraga-Silva, Thais Fernanda de Campos, et al.
Publicado: (2022)

Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?
por: Zorzella-Pezavento, Sofia Fernanda Gonçalves, et al.
Publicado: (2022)

BCG and BCG/DNAhsp65 Vaccinations Promote Protective Effects without Deleterious Consequences for Experimental Autoimmune Encephalomyelitis
por: Zorzella-Pezavento, Sofia Fernanda Gonçalves, et al.
Publicado: (2013)

Experimental Autoimmune Encephalomyelitis Development Is Aggravated by Candida albicans Infection
por: Fraga-Silva, Thais F. C., et al.
Publicado: (2015)

pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity
por: Zorzella-Pezavento, Sofia Fernanda Gonçalves, et al.
Publicado: (2017)

Differential Behavior of Non-albicans Candida Species in the Central Nervous System of Immunocompetent and Immunosuppressed Mice
por: Sanches, Marcelo D’Alessandre, et al.
Publicado: (2019)

Is the BCG Vaccine Safe for Undernourished Individuals?
por: Ishikawa, Larissa Lumi Watanabe, et al.
Publicado: (2012)

Immunization protected well nourished mice but not undernourished ones from lung injury in Methicillin-resistant Staphylococcus aureus (MRSA) infection
por: França, Thais Graziela Donegá, et al.
Publicado: (2009)

Commercial Bovine Proteoglycan Is Highly Arthritogenic and Can Be Used as an Alternative Antigen Source for PGIA Model
por: Ishikawa, Larissa Lumi Watanabe, et al.
Publicado: (2014)

Differential arthritogenicity of Staphylococcus aureus strains isolated from biological samples
por: Colavite-Machado, Priscila Maria, et al.
Publicado: (2013)

Persistent Inflammation in the CNS during Chronic EAE Despite Local Absence of IL-17 Production
por: Zorzella-Pezavento, Sofia Fernanda Gonçalves, et al.
Publicado: (2013)

Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
por: de Toledo, Juliana Helena dos Santos, et al.
Publicado: (2020)

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients
por: Izquierdo, María Jesús, et al.
Publicado: (2012)

Dietary restriction abrogates antibody production induced by a DNA vaccine encoding the mycobacterial 65 kDa heat shock protein
por: Ishikawa, Larissa Lumi Watanabe, et al.
Publicado: (2009)

Severe Changes in Thymic Microenvironment in a Chronic Experimental Model of Paracoccidioidomycosis
por: Alves da Costa, Thiago, et al.
Publicado: (2016)

Correction: Severe Changes in Thymic Microenvironment in a Chronic Experimental Model of Paracoccidioidomycosis
por: Alves da Costa, Thiago, et al.
Publicado: (2016)

Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease
por: Ponce, Daniela, et al.
Publicado: (2023)

Antiapoptotic Effect of Paricalcitol in Gentamicin-induced Kidney Injury
por: Suh, Sang Heon, et al.
Publicado: (2013)

COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels
por: Fernandes de Souza, William Danilo, et al.
Publicado: (2023)

Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease
por: de Boer, Ian H., et al.
Publicado: (2012)

Cost-effectiveness analysis of intravenous paricalcitol vs. oral calcitriol in the treatment of hyperparathyroidism secondary to chronic kidney disease
por: Cardoso, Marilia Mastrocolla de Almeida, et al.
Publicado: (2022)

Paricalcitol Improves the Angiopoietin/Tie-2 and VEGF/VEGFR2 Signaling Pathways in Adriamycin-Induced Nephropathy
por: Deluque, Amanda Lima, et al.
Publicado: (2022)

Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
por: Cheng, Steven, et al.
Publicado: (2006)

Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal Dialysis
por: Stavenuiter, Andrea W. D., et al.
Publicado: (2015)

Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease
por: Lucisano, Silvia, et al.
Publicado: (2015)

Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
por: Cruzado, Josep M., et al.
Publicado: (2017)

Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics
por: Arenas Jimenez, María Dolores, et al.
Publicado: (2021)

Effects of Paricalcitol on Body Composition in Vitamin D-Deficient Rats
por: Koohpeyma, Farhad, et al.
Publicado: (2021)

Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits
por: Chen, Xiu, et al.
Publicado: (2021)

Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation
por: D’Marco, Luis, et al.
Publicado: (2022)

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study
por: Coyne, Daniel W., et al.
Publicado: (2013)

Comparison of the Pharmacological Effects of Paricalcitol and Doxercalciferol on the Factors Involved in Mineral Homeostasis
por: Wu-Wong, J. Ruth, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_p720rr0130hddatrscumre8a7q